Thalidomide Inhibits Granulocyte Responses in Healthy Humans after Ex Vivo Stimulation with Bacterial Antigens

Ingestion of thalidomide was associated with a reduction in the upregulation of the granulocyte activation marker CD11b and a reduced capacity to release elastase and lactoferrin after stimulation with lipopolysaccharide or lipoteichoic acid. A single oral dose of thalidomide attenuates neutrophil a...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Juffermans, Nicole P., Verbon, Annelies, Schultz, Marc J., Hack, C. Erik, van Deventer, Sander J. H., Speelman, Peter, van der Poll, Tom
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Biologic Response Modifiers
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90503/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11302825/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.5.1547-1549.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!